Disclaimer
NovusValue.com is not a broker or dealer, and none of its content represents recommendations to buy or sell securities. Information provided on the site is not intended as investment advice. Novus Value is not liable for damages from using its content, including investment losses. Past performance does not indicate future results, and information is not guaranteed for accuracy or completeness.1-Line Summary
ChromaDex is a bioscience company dedicated to promoting healthy aging through NAD+ research and products.
ChromaDex Corporation is a global bioscience company focused on researching and developing products that promote healthy aging. The company has pioneered studies on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme crucial for cellular metabolism, particularly as levels of NAD+ diminish with age. ChromaDex's most prominent product, Tru Niagen®, utilizes a proprietary form of nicotinamide riboside (NR), which has been shown to safely elevate NAD+ levels in the body. This product stands out in a market that is increasingly interested in wellness and longevity, as evidenced by its strong clinical backing and recognition by several regulatory bodies, including the FDA and Health Canada.
The company operates through three main segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. In the Consumer Products segment, ChromaDex sells its supplement Tru Niagen® directly to consumers and distributors, while the Ingredients segment supplies NR to strategic partners, such as Nestlé. The Analytical Reference Standards and Services segment provides quality control products and services to various industries, ensuring the quality and efficacy of raw materials. ChromaDex's commitment to scientific research is further exemplified by its extensive partnerships with leading research institutions, which inform its product development and marketing strategies.
Automaticly searches the internet using AI for the current investing thesis for ChromaDex Corporation (CDXC) and summarizes it. Only available for paid users.